This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Earnings Stocks Poised to Pop

Rite Aid

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

An earnings short-squeeze play in the retail drugstore chain complex is Rite Aid (RAD - Get Report), which is set to release numbers on Thursday before the market open. This company operates its drugstores in 31 states across the country and in the District of Columbia. Wall Street analysts, on average, expect Rite Aid to report revenue of $6.29 billion on a loss of 12 cents per share.

When Rite Aid reports for this quarter, the company is hoping it can register its third quarter in a row of beating Wall Street estimates. During the last quarter, it beat estimates after reporting a loss of 12 cents per share.

The current short interest as a percentage of the float for Rite Aid sits at 9.7%. That means that out of the 652.81 million shares in the tradable float, 59.56 million are sold short by the bears. This stock has a decent short interest for a name that trades under $5 a share.

From a technical standpoint, this stock is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock put in a near-term bottom at $0.85 back in October, and since then, it has uptrended strong making higher highs and higher lows.

If you're bullish on RAD, I would wait until after its report and buy some shares if the stock breaks out above some near-term overhead resistance at $1.25 a share on heavy volume. Look for volume that's tracking in close to or above its three-month average action of 8,261,500 shares. If we get that action, then look for RAD to make a run at $1.50 a share or possibly much higher if the bulls gain full control of this stock post-earnings.

I would avoid this stock altogether if after its report shares drop back below both its 50-day of $1.13 and 200-day of $1.13 on heavy volume.

Rite Aid shows up on a November list of 11 Stocks Under $11 for a Rebound.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ADBE $74.94 -5.38%
HEI $55.18 3.62%
RTK $1.82 -4.71%
RAD $7.75 -2.02%
TPLM $0.38 -3.75%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs